PMID: 26338394Sep 5, 2015Paper

Glioblastoma: Molecular analysis and its clinical implications

Revista peruana de medicina experimental y salud pública
Carlos A CastañedaLuis Ojeda

Abstract

Glioblastoma (GB) is the most common and most lethal primary brain tumor. Epidemiologic information indicate that its incidence is lower in Hispanic race. Surgery is the only curative strategy and has recently introduced new strategies that increase resection rates. The use of concurrent chemotherapy with radiotherapy improves survival of patients but is associated with toxicity. Improved understanding of molecular biology of GB allows the identification of predictive biomarkers of response and prognosis as well as therapeutic targets for the development of new therapeutic strategies. Among biomarkers are currently available 1p /19q codeletion, IDH mutation and O6-methylguanine DNAmethyltransferase promoter methylation. The identification therapeutic targets enables the development of new drugs and their evaluation in clinical trials, but none has been prospectively validated in phase III clinical trials.

Related Concepts

Related Feeds

Cancer Stem Cells in Glioblastoma

Glioblastoma is the most common and aggressive type of brain tumor. It contains a population of tumor initiating stem cell-like cells known as cancer stem cells. Investigations are ongoing into these cancer stem cells found in these solid tumors which are highly resistance to treatment. Here is the latest research on cancer stem cells in glioblastoma.

Related Papers

Expert Review of Molecular Diagnostics
Emeline TabouretA Idbaih
Topics in Magnetic Resonance Imaging : TMRI
Safwan MotonRivka R Colen
Therapeutische Umschau. Revue thérapeutique
S Hofer
© 2021 Meta ULC. All rights reserved